These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls. Alkhayyat R; Abbas A; Quinn CM; Rakha EA Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539 [TBL] [Abstract][Full Text] [Related]
4. [Application of PLA Method for Detection of p53/p63/p73 Complexes in Situ in Tumour Cells and Tumour Tissue]. Hrabal V; Nekulová M; Nenutil R; Holčaková J; Coates PJ; Vojtěšek B Klin Onkol; 2017; 30(Supplementum1):159-162. PubMed ID: 28471195 [TBL] [Abstract][Full Text] [Related]
5. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival. Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502 [TBL] [Abstract][Full Text] [Related]
6. The Role of HSF1 Protein in Malignant Transformation. Šimončík O; Pastorek M; Vojtěšek B; Müller P Klin Onkol; 2018; 31(Suppl 2):55-62. PubMed ID: 31023025 [TBL] [Abstract][Full Text] [Related]
7. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis. Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932 [TBL] [Abstract][Full Text] [Related]
9. A study of ΔNp63 expression in lung non-small cell carcinomas. Nonaka D Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298 [TBL] [Abstract][Full Text] [Related]
10. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry. Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585 [TBL] [Abstract][Full Text] [Related]
11. HDM2 and HDMX Proteins in Human Cancer. Hároníková L; Vojtěšek B Klin Onkol; 2018; 31(Suppl 2):63-70. PubMed ID: 31023026 [TBL] [Abstract][Full Text] [Related]
12. Expression and Functional Characterization of miR-34c in Cervical Cancer. Sommerová L; Fraňková H; Anton M; Jandáková E; Vojtěšek B; Hrstka R Klin Onkol; 2018; 31(Suppl 2):82-87. PubMed ID: 31023029 [TBL] [Abstract][Full Text] [Related]
13. Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells? Sailer V; Stephan C; Wernert N; Perner S; Jung K; Dietel M; Kristiansen G Histopathology; 2013 Jul; 63(1):50-6. PubMed ID: 23668398 [TBL] [Abstract][Full Text] [Related]
14. p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved. Walsh NM; Saggini A; Pasternak S; Carter MD; Fleming K; Ly TY; Doucette S Hum Pathol; 2020 Mar; 97():60-67. PubMed ID: 31978504 [TBL] [Abstract][Full Text] [Related]
15. Pan-p63 but not ΔNp63 (p40) expression in undifferentiated carcinoma of the pancreas. Liszka Ł Pol J Pathol; 2020; 71(2):155-172. PubMed ID: 32729306 [TBL] [Abstract][Full Text] [Related]
16. Importance of Membrane Proteins in the Treatment of Tumor Diseases and the Possibilities of Their Further Study. Dosedělová L; Nekulová M; Zahradníková M; Faktor J; Vojtěšek B; Hernychová L Klin Onkol; 2018; 31(Suppl 2):32-40. PubMed ID: 31023022 [TBL] [Abstract][Full Text] [Related]
17. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology. Khazai L; Agosto-Arroyo E; Rosa M Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030 [TBL] [Abstract][Full Text] [Related]
18. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955 [TBL] [Abstract][Full Text] [Related]
19. Prima-1 and APR-246 in Cancer Therapy. Zatloukalová P; Galoczová M; Vojtěšek B Klin Onkol; 2018; 31(Suppl 2):71-76. PubMed ID: 31023027 [TBL] [Abstract][Full Text] [Related]
20. Benign and malignant odontogenic neoplasms of the jaws show a concordant nondiscriminatory p63/p40 positive immunophenotype. Argyris PP; Malz C; Taleb R; Koutlas IG Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Dec; 126(6):506-512. PubMed ID: 30309829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]